Reaction Details |
 | Report a problem with these data |
Target | Sphingosine 1-phosphate receptor Edg-5/Sphingosine 1-phosphate receptor Edg-3 |
---|
Ligand | BDBM50148421 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_201323 |
---|
IC50 | >10000±n/a nM |
---|
Citation | Hale JJ; Doherty G; Toth L; Mills SG; Hajdu R; Keohane CA; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Forrest M; Sun SY; West S; Xie H; Nomura N; Rosen H; Mandala S Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists. Bioorg Med Chem Lett 14:3501-5 (2004) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Sphingosine 1-phosphate receptor Edg-5/Sphingosine 1-phosphate receptor Edg-3 |
---|
Name: | Sphingosine 1-phosphate receptor Edg-5/Sphingosine 1-phosphate receptor Edg-3 |
Synonyms: | S1P2 | Sphingosine 1-phosphate receptor | Sphingosine 1-phosphate receptor Edg-5 | Sphingosine-1-phosphate receptor 2 | ndothelial differentiation G-protein coupled receptor 5 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 38883.16 |
Organism: | Homo sapiens (Human) |
Description: | Membranes isolated from S1P2-transfected CHO cells were used in ligand binding assay. |
Residue: | 353 |
Sequence: | MGSLYSEYLNPNKVQEHYNYTKETLETQETTSRQVASAFIVILCCAIVVENLLVLIAVAR
NSKFHSAMYLFLGNLAASDLLAGVAFVANTLLSGSVTLRLTPVQWFAREGSAFITLSASV
FSLLAIAIERHVAIAKVKLYGSDKSCRMLLLIGASWLISLVLGGLPILGWNCLGHLEACS
TVLPLYAKHYVLCVVTIFSIILLAIVALYVRIYCVVRSSHADMAAPQTLALLKTVTIVLG
VFIVCWLPAFSILLLDYACPVHSCPILYKAHYFFAVSTLNSLLNPVIYTWRSRDLRREVL
RPLQCWRPGVGVQGRRRGGTPGHHLLPLRSSSSLERGMHMPTSPTFLEGNTVV
|
|
|
BDBM50148421 |
---|
n/a |
---|
Name | BDBM50148421 |
Synonyms: | CHEMBL119413 | [3-(3-Chloro-4-octyloxy-benzylamino)-propyl]-phosphonic acid |
Type | Small organic molecule |
Emp. Form. | C18H31ClNO4P |
Mol. Mass. | 391.87 |
SMILES | CCCCCCCCOc1ccc(CNCCCP(O)(O)=O)cc1Cl |
Structure |
|